Neural cell adhesion molecule (CD56)-positive B-cell lymphoma

European Journal of Haematology

Volumn 79, Issue 2, 2007, Pages 166-169

  Isobe, Yasushi ^a   Sugimoto, Koichi ^a   Takeuchi, Kengo ^b   Ando, Jun ^a   Masuda, Azuchi ^a   Mori, Takeshi ^a   Oshimi, Kazuo ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b CANCER INSTITUTE   (Japan)

Author keywords

B cell lymphoma; BCL2 gene; CD56; Germinal center; Homotypic adhesion

Indexed keywords

CD56 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; NERVE CELL ADHESION MOLECULE; PROTEIN BCL 6;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CASE REPORT; CELL AGGREGATION; CELL GROWTH; FOLLICULAR LYMPHOMA; GERMINAL CENTER; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPHOMA CELL; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD56; FEMALE; HUMANS; LYMPHOMA, B-CELL; MALE;

EID: 34447307976     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2007.00893.x     Document Type: Article

References (12)

1. Povlsen GK, Ditlevsen DK, Berezin V, Bock E. Intracellular signaling by the neural cell adhesion molecule. Neurochem Res 2003 28 : 127 41.
2. Christofori G. Changing neighbours, changing behaviour: cell adhesion molecule-mediated signaling during tumour progression. EMBO J 2003 22 : 2318 23.
3. Pallat-Deceunynck C, Barille S, Puthier D, Rapp ML, Harousseau JL, Bataille R, Amiot M. Adhesion molecules on human myeloma cells: significant changes in expression related to malignancy, tumor spreading, and immortalization. Cancer Res 1995 55 : 2647 3653.
4. Chan JKC, Sin VC, Wong KF, Ng CS, Tsang WYW, Chan CH, Cheung MMC, Lau WH. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 1997 89 : 4501 13.
5. Raspadori D, Damiani D, Lenoci M, et al. CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis. Leukemia 2001 15 : 1161 4.
6. Hammer RD, Vnencak-Jones CL, Manning BS, Glick AD, Kinney MC. Microvillous lymphomas are B-cell neoplasms that frequently express CD56. Mod Pathol, 1998 11 : 239 46.
7. Weisberger J, Gorczyca W, Kinney MC. CD56-positive large B-cell lymphoma. Appl Immunohistochem Mol Morphol 2006 14 : 369 74.
8. Muroi K, Omine K, Kuribara R, Uchida M, Izumi T, Hatake K, Miura Y. CD56 expression in B-cell lymphoma. Leukemia Res 1998 22 : 201 2.
9. Sekita T, Tamaru J, Isobe K, Harigaya K, Masuoka S, Katayama T, Kobayashi M, Mikata A. Diffuse large B cell lymphoma expressing the natural killer cell marker CD56. Pathol Int 1999 49 : 752 8.
10. Küppers R, Klein U, Hansmann M, Rajewsky K. Cellular origin of human B-cell lymphomas. New Engl J Med 1999 341 : 1520 9.
11. Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004 103 : 275 82.
12. Vega F, Chang CC, Medeiros LJ, et al. Plasmablastic lymphoma and plasmablastic plasma cell myeloma have nearly identical immunophenotypic profiles. Mod Pathol 2005 18 : 806 15.